About: http://data.cimple.eu/news-article/f970cf6e540a613519d09a23df41cad74eb2e66d1b593eaadb2026dd

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/f970cf6e540a613519d09a23df41cad74eb2e66d1b593eaadb2026dd Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The backer of Russia's Sputnik V coronavirus vaccine said Monday it had signed an agreement with an India-based pharmaceuticals giant for the production of up to 200 million doses of the jab a year. The Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund, said in a statement it has partnered with the Virchow Group to produce up to 200 million doses of the two-dose vaccine in India every year. Virchow Biotech, a subsidiary of the Virchow Group, is expected to start full-scale commercial production in the first half of 2021, it said. RDIF CEO Kirill Dmitriev said the agreement was "an important step to facilitate the full-scale local production" of the two-dose Sputnik V vaccine in India and to supply partners around the world. In a separate statement, RDIF said that over the past week it had secured production agreements with two other Indian manufacturers: Stelis Biopharma and Gland Pharma. The companies will produce enough doses for 300 million people a year, RDIF said. It added that Sputnik V has "production capacity for more than 700 million people secured in 10 countries", without providing further details. According to RDIF, Russia's vaccine, which is named after the Soviet-era satellite, has been registered in 54 countries. Moscow registered the vaccine in August before large-scale clinical trials, but leading medical journal The Lancet has since said it is safe and over 90 percent effective. Some Western countries have been wary of Sputnik over concerns the Kremlin is using it as a soft power tool to advance its interests. acl/emg/jv
schema:headline	Indian firm to make 200 mn doses of Russia's Sputnik V
schema:mentions	Electromyography Satellite television Medical journal Sovereign wealth fund Sputnik 1 The Lancet Jab Moscow Chief executive officer Russia India Vaccine Severe acute respiratory syndrome coronavirus 2 Gland Rudolf Virchow Stelis Kirill Dmitriev Soft power Russian Direct Investment Fund Anterior cruciate ligament Government of Russia
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-22 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software